Proprietary Complex Generics Pipeline

About Rafarm

Rafarm is a well-established, privately-held Greek pharmaceutical manufacturer with a nearly 50-year history, now pivoting to a hybrid business model combining generic drug development, advanced CDMO services, and out-licensing. Its core technological expertise lies in complex sterile formulations, particularly ophthalmics and injectables, supported by ongoing investments in modern production lines. The company aims to leverage its scientific expertise and agile operations to accelerate drug development for partners and expand its international footprint through dossier licensing and product supply.

Therapeutic Areas